Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Avdili, A; Rohrhofer, L; Auer, M; Bernecker, C; Schlenke, P; Dorn, I.
Generation of the human erythroblast-derived iPSC line UBTi001-A
STEM CELL RES. 2022; 64: 102910
Doi: 10.1016/j.scr.2022.102910
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
-
Avdili Afrim
- Co-authors Med Uni Graz
-
Auer Martina
-
Bernecker Claudia
-
Dorn Isabel
-
Rohrhofer Lisa
-
Schlenke Peter
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- We performed reprogramming of human erythroblasts derived from CD34+ hematopoietic stem / progenitor cells of a healthy donor. CD34+ cells were differen-tiated in-vitro into a pure population of CD36+ erythroblasts and nucleofected with four episomal plasmids expressing SOX2, OCT3/4, KLF4, LIN28, L-MYC and TP53-shRNA. The established iPSC line showed normal karyotype. Pluripotency was confirmed by expression of pluripotency markers and in-vitro differentiation into tissues of all three germ layers. The UBTi001-A iPSC line might provide an attractive source for developmental research on human hematopoiesis and erythropoiesis.